Johnson & Johnson suspends Covid vaccine trial as participant falls ill


WASHINGTON: Johnson & Johnson said on Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants fell ill.
“We have temporarily suspended additional dosing in all of our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to unexplained illness in a study participant,” the company said. in a press release.
The hiatus means the online registration system has been shut down for the 60,000 patient clinical trial while the independent patient safety committee is convened.


Please enter your comment!
Please enter your name here